Adhesion molecules in subjects with COPD and healthy non-smokers: A cross sectional parallel group study

Respiratory Research

Volumn 14, Issue 1, 2013, Pages

  Blidberg, Kristin ^a   Palmberg, Lena ^a   James, Anna ^a   Billing, Bo ^b   Henriksson, Elisabeth ^b   Lantz, Ann Sofie ^b   Larsson, Kjell ^a   Dahlén, Barbro ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adhesion molecules; Bronchoialveolar lavage fluid; Chronic Obstructive Pulmonary Disease; Neutrophils; Sputum

Indexed keywords

CD11B ANTIGEN; CD31 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1; CELL ADHESION MOLECULE;

ADULT; ARTICLE; BLOOD SAMPLING; BRONCHOSCOPY; BRONCHUS BIOPSY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG LAVAGE; MALE; NEUTROPHIL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SMOKING; SPUTUM ANALYSIS; IMMUNOLOGY; LEUKOCYTE ACTIVATION; MIDDLE AGED; PATHOLOGY; REFERENCE VALUE;

CELL ADHESION MOLECULES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUTROPHIL ACTIVATION; NEUTROPHILS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REFERENCE VALUES; SMOKING;

EID: 84876803538     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-14-47     Document Type: Article

References (41)

1. Di Stefano A, Capelli A, Lusuardi M, Balbo P, Vecchio C, Maestrelli P, Mapp CE, Fabbri LM, Donner CF, Saetta M. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med 1998, 158(4):1277-1285. 10.1164/ajrccm.158.4.9802078, 9769292.
2. Pesci A, Balbi B, Majori M, Cacciani G, Bertacco S, Alciato P, Donner CF. Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. Eur Respir J 1998, 12(2):380-386. 10.1183/09031936.98.12020380, 9727789.
3. Pesci A, Majori M, Cuomo A, Borciani N, Bertacco S, Cacciani G, Gabrielli M. Neutrophils infiltrating bronchial epithelium in chronic obstructive pulmonary disease. Respir Med 1998, 92(6):863-870. 10.1016/S0954-6111(98)90389-4, 9850371.
4. Dentener MA, Louis R, Cloots RH, Henket M, Wouters EF. Differences in local versus systemic TNFalpha production in COPD: inhibitory effect of hyaluronan on LPS induced blood cell TNFalpha release. Thorax 2006, 61(6):478-484. 10.1136/thx.2005.053330, 2111229, 16517575.
5. Agusti A, Soriano JB. COPD as a systemic disease. COPD 2008, 5(2):133-138. 10.1080/15412550801941349, 18415812.
6. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 2007, 7(9):678-689. 10.1038/nri2156, 17717539.
7. Muller WA. Mechanisms of leukocyte transendothelial migration. Annu Rev Pathol 2011, 6:323-344. 10.1146/annurev-pathol-011110-130224, 3628537, 21073340.
8. Woodfin A, Voisin MB, Nourshargh S. Recent developments and complexities in neutrophil transmigration. Curr Opin Hematol 2010, 17(1):9-17. 10.1097/MOH.0b013e3283333930, 2882030, 19864945.
9. Muller WA. The role of PECAM-1 (CD31) in leukocyte emigration: studies in vitro and in vivo. J Leukoc Biol 1995, 57(4):523-528.
10. Christofidou-Solomidou M, Nakada MT, Williams J, Muller WA, DeLisser HM. Neutrophil platelet endothelial cell adhesion molecule-1 participates in neutrophil recruitment at inflammatory sites and is down-regulated after leukocyte extravasation. J Immunol 1997, 158(10):4872-4878.
11. Arnaout MA. Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood 1990, 75(5):1037-1050.
12. Noguera A, Batle S, Miralles C, Iglesias J, Busquets X, MacNee W, Agusti AG. Enhanced neutrophil response in chronic obstructive pulmonary disease. Thorax 2001, 56(6):432-437. 10.1136/thorax.56.6.432, 1746080, 11359957.
13. Maestrelli P, Calcagni PG, Saetta M, Bertin T, Mapp CE, Sanna A, Veriter C, Fabbri LM, Stanescu D. Integrin upregulation on sputum neutrophils in smokers with chronic airway obstruction. Am J Respir Crit Care Med 1996, 154(5):1296-1300. 10.1164/ajrccm.154.5.8912739, 8912739.
14. Larsson BM, Palmberg L, Malmberg PO, Larsson K. Effect of exposure to swine dust on levels of IL-8 in airway lavage fluid. Thorax 1997, 52(7):638-642. 10.1136/thx.52.7.638, 1758613, 9246137.
15. Strandberg K, Ek A, Palmberg L, Larsson K. Fluticasone and ibuprofen do not add to the effect of salmeterol on organic dust-induced airway inflammation and bronchial hyper-responsiveness. J Intern Med 2008, 264(1):83-94. 10.1111/j.1365-2796.2008.01928.x, 18298484.
16. Britten KM, Howarth PH, Roche WR. Immunohistochemistry on resin sections: a comparison of resin embedding techniques for small mucosal biopsies. Biotech Histochem 1993, 68(5):271-280. 10.3109/10520299309105629, 8268322.
17. Donaldson GC, Seemungal TA, Patel IS, Bhowmik A, Wilkinson TM, Hurst JR, Maccallum PK, Wedzicha JA. Airway and systemic inflammation and decline in lung function in patients with COPD. Chest 2005, 128(4):1995-2004. 10.1378/chest.128.4.1995, 16236847.
18. Ryder MI, Fujitaki R, Lebus S, Mahboub M, Faia B, Muhaimin D, Hamada M, Hyun W. Alterations of neutrophil L-selectin and CD18 expression by tobacco smoke: implications for periodontal diseases. J Periodontal Res 1998, 33(6):359-368. 10.1111/j.1600-0765.1998.tb02211.x, 9777587.
19. Noguera A, Sala E, Pons AR, Iglesias J, MacNee W, Agusti AG. Expression of adhesion molecules during apoptosis of circulating neutrophils in COPD. Chest 2004, 125(5):1837-1842. 10.1378/chest.125.5.1837, 15136398.
20. Makris D, Vrekoussis T, Izoldi M, Alexandra K, Katerina D, Dimitris T, Michalis A, Tzortzaki E, Siafakas NM, Tzanakis N. Increased apoptosis of neutrophils in induced sputum of COPD patients. Respir Med 2009, 103(8):1130-1135. 10.1016/j.rmed.2009.03.002, 19329291.
21. Noguera A, Busquets X, Sauleda J, Villaverde JM, MacNee W, Agusti AG. Expression of adhesion molecules and G proteins in circulating neutrophils in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 158(5 Pt 1):1664-1668.
22. Condliffe AM, Chilvers ER, Haslett C, Dransfield I. Priming differentially regulates neutrophil adhesion molecule expression/function. Immunology 1996, 89(1):105-111. 10.1046/j.1365-2567.1996.d01-711.x, 1456672, 8911147.
23. Lams BE, Sousa AR, Rees PJ, Lee TH. Subepithelial immunopathology of the large airways in smokers with and without chronic obstructive pulmonary disease. Eur Respir J 2000, 15(3):512-516. 10.1034/j.1399-3003.2000.15.14.x, 10759445.
24. Saetta M, Di Stefano A, Turato G, Facchini FM, Corbino L, Mapp CE, Maestrelli P, Ciaccia A, Fabbri LM. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 157(3 Pt 1):822-826.
25. Battaglia S, Mauad T, van Schadewijk AM, Vignola AM, Rabe KF, Bellia V, Sterk PJ, Hiemstra PS. Differential distribution of inflammatory cells in large and small airways in smokers. J Clin Pathol 2007, 60(8):907-911. 1994511, 16917001.
26. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004, 350(26):2645-2653. 10.1056/NEJMoa032158, 15215480.
27. Di Stefano A, Caramori G, Gnemmi I, Contoli M, Bristot L, Capelli A, Ricciardolo FL, Magno F, D'Anna SE, Zanini A. Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD. Thorax 2009, 64(11):968-975. 10.1136/thx.2009.113647, 19703829.
28. Schumacher A, Liebers U, John M, Gerl V, Meyer M, Witt C, Wolff G. P-selectin glycoprotein ligand-1 (PSGL-1) is up-regulated on leucocytes from patients with chronic obstructive pulmonary disease. Clin Exp Immunol 2005, 142(2):370-376. 10.1111/j.1365-2249.2005.02920.x, 1809501, 16232226.
29. Maclay JD, McAllister DA, Johnston S, Raftis J, McGuinnes C, Deans A, Newby DE, Mills NL, MacNee W. Increased platelet activation in patients with stable and acute exacerbation of COPD. Thorax 2011, 66(9):769-774. 10.1136/thx.2010.157529, 21507906.
30. Walter RE, Wilk JB, Larson MG, Vasan RS, Keaney JF, Lipinska I, O'Connor GT, Benjamin EJ. Systemic inflammation and COPD: the Framingham Heart Study. Chest 2008, 133(1):19-25. 10.1378/chest.07-0058, 17908709.
31. Ferroni P, Basili S, Martini F, Vieri M, Labbadia G, Cordova C, Alessandri C, Gazzaniga PP. Soluble P-selectin as a marker of platelet hyperactivity in patients with chronic obstructive pulmonary disease. J Investig Med 2000, 48(1):21-27.
32. Riise GC, Larsson S, Lofdahl CG, Andersson BA. Circulating cell adhesion molecules in bronchial lavage and serum in COPD patients with chronic bronchitis. Eur Respir J 1994, 7(9):1673-1677. 10.1183/09031936.94.07091673, 7527787.
33. Di Stefano A, Maestrelli P, Roggeri A, Turato G, Calabro S, Potena A, Mapp CE, Ciaccia A, Covacev L, Fabbri LM. Upregulation of adhesion molecules in the bronchial mucosa of subjects with chronic obstructive bronchitis. Am J Respir Crit Care Med 1994, 149(3 Pt 1):803-810.
34. Leeuwenberg JF, Smeets EF, Neefjes JJ, Shaffer MA, Cinek T, Jeunhomme TM, Ahern TJ, Buurman WA. E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. Immunology 1992, 77(4):543-549. 1421640, 1283598.
35. Pigott R, Dillon LP, Hemingway IH, Gearing AJ. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun 1992, 187(2):584-589. 10.1016/0006-291X(92)91234-H, 1382417.
36. Mendez MP, Morris SB, Wilcoxen S, Du M, Monroy YK, Remmer H, Murphy H, Christensen PJ, Paine R. Disparate mechanisms of sICAM-1 production in the peripheral lung: contrast between alveolar epithelial cells and pulmonary microvascular endothelial cells. Am J Physiol Lung Cell Mol Physiol 2008, 294(4):L807-814. 10.1152/ajplung.00398.2007, 18281605.
37. Barnett CC, Moore EE, Moore FA, Carl VS, Biffl WL. Soluble ICAM-1 (sICAM-1) provokes PMN elastase release. J Surg Res 1996, 63(1):6-10. 10.1006/jsre.1996.0213, 8661163.
38. Schmal H, Czermak BJ, Lentsch AB, Bless NM, Beck-Schimmer B, Friedl HP, Ward PA. Soluble ICAM-1 activates lung macrophages and enhances lung injury. J Immunol 1998, 161(7):3685-3693.
39. Beck-Schimmer B, Madjdpour C, Kneller S, Ziegler U, Pasch T, Wuthrich RP, Ward PA, Schimmer RC. Role of alveolar epithelial ICAM-1 in lipopolysaccharide-induced lung inflammation. Eur Respir J 2002, 19(6):1142-1150. 10.1183/09031936.02.00236602, 12108870.
40. Muller WA, Weigl SA, Deng X, Phillips DM. PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 1993, 178(2):449-460. 10.1084/jem.178.2.449, 2191108, 8340753.
41. Gane J, Stockley R. Mechanisms of neutrophil transmigration across the vascular endothelium in COPD. Thorax 2012, 67(6):553-561. 10.1136/thoraxjnl-2011-200088, 21543441.